Physician profile
Robert Lightfoot
NPI 1891258786
$1,759.73
in general payments reported to CMS, 2019-2025
10 companies · $221 in 2025
The $221 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,539 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,404 · Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,403.72 |
| Food and Beverage | $356.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,420.71 | 2024 | |
| Integra Lifesciences Corporation | $119.98 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Janssen Pharmaceuticals, INC | $53.41 | 2024 | Xarelto |
| Novo Nordisk INC | $39.39 | 2025 | Wegovy, Ozempic |
| Smith+Nephew, INC. | $27.07 | 2025 | Renasys Go V2 Home |
| Vertex Pharmaceuticals Incorporated | $26.14 | 2025 | |
| Lundbeck LLC | $25.49 | 2025 | Rexulti |
| Exact Sciences Corporation | $16.32 | 2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $15.62 | 2025 | Rexulti |
| Glaxosmithkline, LLC. | $15.60 | 2025 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lightfoot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.